Literature DB >> 25792537

Healthcare providers' perspectives on expedited partner therapy for chlamydia: a qualitative study.

Elian A Rosenfeld1, John Marx2, Martha A Terry2, Ron Stall2, Chelsea Pallatino2, Elizabeth Miller3.   

Abstract

OBJECTIVES: Expedited partner therapy (EPT) effectively reduces rates of reinfection with chlamydia and increases the number of partners treated for the infection. Healthcare provider (HCP) provision of EPT is low. The objective of this qualitative study was to understand HCP views and opinions regarding the use of EPT in a state where EPT is permissible but underused.
METHODS: Using a purposive sampling strategy to include diverse HCPs who treat young women at risk for chlamydia, 23 semistructured, in-depth interviews were conducted between October and December 2013. The interviews included questions about knowledge, attitudes, experiences with, and barriers and facilitators regarding the use of EPT.
RESULTS: Many respondents report using EPT and believe the practice is beneficial for their patients. Most providers were unaware of their colleagues' practices and had limited knowledge regarding institutional policies around EPT. HCPs noted a variety of barriers, such as fear of liability, confusion around the legal status of EPT and not being able to counsel patients' partners that make routine use of this practice a challenge. Facilitators of EPT include speaking on the phone with patients' partners and establishing legislation enabling EPT.
CONCLUSIONS: This is the first study to qualitatively examine HCPs' perspectives on EPT in the USA. Barriers to EPT, including concerns about counselling patients' partners and the legal status of EPT, can be overcome. EPT recommendations could include the use of phone calls as part of their guidelines. Changing EPT legislation at the state level in the USA is an important factor to facilitate EPT use. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  ATTITUDES; CHLAMYDIA INFECTION; PARTNER NOTIFICATION; QUALITATIVE RESEARCH

Mesh:

Year:  2015        PMID: 25792537     DOI: 10.1136/sextrans-2014-051873

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  6 in total

1.  Expedited Partner Therapy: Combating Record High Sexually Transmitted Infection Rates.

Authors:  Cornelius D Jamison; Tammy Chang; Okeoma Mmeje
Journal:  Am J Public Health       Date:  2018-10       Impact factor: 9.308

2.  Healthcare providers and community perspectives on expedited partner therapy (EPT) for use with gay, bisexual and other men who have sex with men.

Authors:  Kristi E Gamarel; Raha Mouzoon; Alejandro Rivas; Rob Stephenson; Okeoma Mmeje
Journal:  Sex Transm Infect       Date:  2019-09-11       Impact factor: 3.519

3.  A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands.

Authors:  Anita C Nanhoe; Maartje Visser; Jurriaan J Omlo; Anita J C M Watzeels; Ingrid V van den Broek; Hannelore M Götz
Journal:  BMC Infect Dis       Date:  2018-05-29       Impact factor: 3.090

4.  Impact of an Electronic Medical Record Best Practice Alert on Expedited Partner Therapy for Chlamydia Infection and Reinfection.

Authors:  Sarah J Willis; Heather Elder; Noelle M Cocoros; Myfanwy Callahan; Katherine K Hsu; Michael Klompas
Journal:  Open Forum Infect Dis       Date:  2021-11-16       Impact factor: 3.835

5.  Barriers and Facilitators of Partner Treatment of Chlamydia: A Qualitative Investigation with Prescribers and Community Pharmacists.

Authors:  Helen Wood; Caroline Hall; Emma Ioppolo; Renée Ioppolo; Ella Scacchia; Rhonda Clifford; Sajni Gudka
Journal:  Pharmacy (Basel)       Date:  2018-02-08

6.  Decreasing Chlamydial Reinfections in a Female Urban Population.

Authors:  Jennifer Denise Suarez; Kristin Snackey Alvarez; Sharon Anderson; Helen King; Emily Kirkpatrick; Michael Harms; Robert Martin; Emily Adhikari
Journal:  Sex Transm Dis       Date:  2021-12-01       Impact factor: 2.830

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.